U.S. stocks move: 10x Genomics surged on October 9th due to target price upgrade, Fred Hutchinson collaboration, and spatial genomics.
Bitget异动解读2026/10/09 14:0510x Genomics October 9th Surge Analysis
Keywords: Target Price Raise, Fred Collaboration, Spatial Omics
1. On October 9th, BofA Securities raised the target price for 10x Genomics from $50 to $80 and maintained a hold rating.
2. On October 7th, the company reached a multi-project research collaboration with Fred Hutchinson Cancer Center, utilizing the Flex Apex, Xenium, and upcoming Atera platforms to conduct biomarker discovery in bladder cancer and minimal residual disease detection in acute myeloid leukemia, driving the application of single-cell and spatial technologies into clinical research of solid tumors and hematologic malignancies.
(Disclaimer: This content is generated by AI technology based on public information summary, for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Libya Hamada and Al-Taharah oil fields resume production
No rate hike in October, another move in December? Fed's "slow rate hike" path against inflation emerges, all eyes on Waller's speech next week
The Federal Reserve is set to announce its latest interest rate decision next Wednesday. The market generally expects the central bank to keep the federal funds rate unchanged, which would signal its patience in combating inflation.
Crypto prices
More
